Effectiveness of Interventions to Promote Physical Activity During Pregnancy
SLMM
2 other identifiers
interventional
60
1 country
1
Brief Summary
Pregnant women are more sedentary (sit, recline, lie down more) on average than non-pregnant women (more than 12 versus less than 8 waking sedentary hours/day). Sedentary behavior has been related to psychological distress, pregnancy weight gain, impaired sleep and very large size infants, while adequate physical activity has been found to improve mental health, decrease risk of high blood pressure in pregnancy and lower risk of preterm birth infants (less than 37 weeks gestation). Decreased sedentary behavior and increased physical activity may be crucial and neglected lifestyle behavior changes that can be promoted to reduce these and other maternal health and birth outcome problems among pregnant women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pregnancy
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2025
CompletedFirst Posted
Study publicly available on registry
October 31, 2025
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2027
March 11, 2026
March 1, 2026
1.5 years
October 15, 2025
March 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from first two weeks (baseline) ActiGraph device measured weekly moderate-intensity physical activity in minutes/week and time spent in sedentary behavior in hours per day
Change from first two weeks moderate-intensity physical activity in minutes per week and sedentary time measures in hours per day, baseline measure by participant blinded ActiGraph at 8 to 12 weeks gestation, prior to the intervention beginning with goal of pregnancy recommended moderate-intensity physical activity using CDC talk test of 150 minutes/week measured by Fitbit and sedentary time 8 hours/day or less. The intervention begins at 10 to 14 weeks gestation. ActiGraph device measured change from 8 to 12 week baseline physical activity and sedentary time as described above is measured again at 18 to 22 weeks gestation, and 28 to 32 weeks gestation in minutes of moderate-intensity physical activity per week and hours of sedentary time per day.
Intervention begins at 10-14 weeks gestation; 18-22 weeks gestation ActiGraph measured weekly PA & ST; 28 -32 weeks gestation ActiGraph measured weekly PA & ST; Fitbit measured weekly PA & daily ST measured 10-14 to 28-32 weeks gestation
Secondary Outcomes (4)
Feasibility of recruitment for the study
6 months (January 2026 through June 2026)
Feasibility of retention in the SLMM intervention
10 to 14 weeks gestation start of SLMM per participant through 28 to 32 weeks gestation
Feasibility of adherence to the SLMM intervention
10-14 weeks gestation through 28 to 32 weeks gestation
Acceptability of the SLMM Intervention to participants
18 to 22 weeks gestation and 28 to 32 weeks gestation
Study Arms (1)
Sit Less, Move More (SLMM) program intervention
EXPERIMENTALHealth Coaching sessions and text messages; Fitbit sedentary time disruption, monitoring, self-regulation, exercise with a partner most days of the week to ACOG opinion 804 recommended physical activity
Interventions
Health Coach sessions and SMS texts ramp up to goal ACOG opinion 804 pregnancy physical activity; wearable device activity tracker (Fitbit) for monitoring and self-regulation, exercise with a partner for support and accountability most days of the week.
Eligibility Criteria
You may not qualify if:
- Women with physical activity restrictions (e.g., placenta previa) that prevent them from completing ACOG recommended pregnancy physical activity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Orlando Health
Orlando, Florida, 32806, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean W Davis, PhD, DNP, EdD
University of Central Florida
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Participant baseline physical activity is masked to the participant
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 15, 2025
First Posted
October 31, 2025
Study Start
February 1, 2026
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 31, 2027
Last Updated
March 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be shared after publications and initial presentations, anticipated to be 1 year following the final data analysis 1/1/2029
- Access Criteria
- All de-identified participant data will be stored. No PHI or identifiable participant data from this study is stored in OpenICPSR. Users are required to apply for access to restricted data. Additionally, non-members will be charged $825 to access the data (this includes the administrative fee to access data in the virtual data enclave) plus a $349 administrative fee for secure download." https://www.openicpsr.org/openicpsr/faqs Further details are available here: https://www.openicpsr.org/openicpsr/accessRD;jses
DATA MANAGEMENT AND SHARING PLAN below and through OpenICPSR according to its terms and conditions. Following the study and initial publications, data will be shared per NIH - NICHD requirements. The de-identified data will be housed indefinitely in the OpenICPSR databank administered by the University of Michigan. Access occurs by open access to researchers of member organizations such as UCF and otherwise through approved requests for research purposes. All de-identified participant data will be stored. No PHI or identifiable participant data from this study is stored in OpenICPSR. Users are required to apply for access to restricted data. Additionally, non-members will be charged $825 to access the data (this includes the administrative fee to access data in the virtual data enclave) plus a $349 administrative fee for secure download." https://www.openicpsr.org/openicpsr/faqs Further details are available here: https://www.openicpsr.org/openicpsr/accessRD;jses